Pyelonephritis: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett mNo edit summary |
imported>Meg Taylor (subpages) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[medicine]], '''pyelonephritis''' is a form of [[urinary tract infection]] that is "inflammation of the [[kidney]] involving the renal parenchyma (the nephrons); kidney pelvis; and kidney calices. It is characterized by abdominal pain; fever; nausea; vomiting; and occasionally diarrhea."<ref>{{MeSH}}</ref> | In [[medicine]], '''pyelonephritis''' is a form of [[urinary tract infection]] that is "inflammation of the [[kidney]] involving the renal parenchyma (the nephrons); kidney pelvis; and kidney calices. It is characterized by abdominal pain; fever; nausea; vomiting; and occasionally diarrhea."<ref>{{MeSH}}</ref> | ||
==Treatment== | |||
[[Antibiotic]]s may be given by mouth or intravenously for adults<ref name="pmid17943784">{{cite journal |author=Pohl A |title=Modes of administration of antibiotics for symptomatic severe urinary tract infections |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD003237 |year=2007 |pmid=17943784 |doi=10.1002/14651858.CD003237.pub2 |url=http://dx.doi.org/10.1002/14651858.CD003237.pub2 |issn=}}</ref> or children<ref name="pmid17611232">{{cite journal |author=Montini G, Toffolo A, Zucchetta P, ''et al'' |title=Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial |journal=BMJ |volume=335 |issue=7616 |pages=386 |year=2007 |month=August |pmid=17611232 |pmc=1955287 |doi=10.1136/bmj.39244.692442.55 |url=http://bmj.com/cgi/pmidlookup?view=long&pmid=17611232 |issn=}}</ref>. | |||
In children, 3 versus 8 days of intravenous [[antibiotic]]s had similar outcomes.<ref name="pmid18267977">{{cite journal |author=Bouissou F, Munzer C, Decramer S, ''et al'' |title=Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months |journal=Pediatrics |volume=121 |issue=3 |pages=e553–60 |year=2008 |month=March |pmid=18267977 |doi=10.1542/peds.2006-3632 |url=http://pediatrics.aappublications.org/cgi/pmidlookup?view=long&pmid=18267977 |issn=}}</ref> | |||
==Prognosis== | ==Prognosis== | ||
Latest revision as of 17:27, 30 September 2009
In medicine, pyelonephritis is a form of urinary tract infection that is "inflammation of the kidney involving the renal parenchyma (the nephrons); kidney pelvis; and kidney calices. It is characterized by abdominal pain; fever; nausea; vomiting; and occasionally diarrhea."[1]
Treatment
Antibiotics may be given by mouth or intravenously for adults[2] or children[3].
In children, 3 versus 8 days of intravenous antibiotics had similar outcomes.[4]
Prognosis
About 15% of patients persist with fever after 48 hours of antibiotics.[5]
References
- ↑ Anonymous (2024), Pyelonephritis (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Pohl A (2007). "Modes of administration of antibiotics for symptomatic severe urinary tract infections". Cochrane Database Syst Rev (4): CD003237. DOI:10.1002/14651858.CD003237.pub2. PMID 17943784. Research Blogging.
- ↑ Montini G, Toffolo A, Zucchetta P, et al (August 2007). "Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial". BMJ 335 (7616): 386. DOI:10.1136/bmj.39244.692442.55. PMID 17611232. PMC 1955287. Research Blogging.
- ↑ Bouissou F, Munzer C, Decramer S, et al (March 2008). "Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at 9 months". Pediatrics 121 (3): e553–60. DOI:10.1542/peds.2006-3632. PMID 18267977. Research Blogging.
- ↑ Grover SA, Komaroff AL, Weisberg M, Cook EF, Goldman L (1987). "The characteristics and hospital course of patients admitted for presumed acute pyelonephritis". J Gen Intern Med 2 (1): 5–10. PMID 3543268. [e]